Literature DB >> 24759558

Expressions and roles of periostin in otolaryngological diseases.

Nobuo Ohta1, Akihiro Ishida1, Kazuya Kurakami1, Yusuke Suzuki1, Seiji Kakehata1, Junya Ono2, Hiroki Ikeda3, Kimihiro Okubo4, Kenji Izuhara5.   

Abstract

Periostin is a 90-kDa member of the fasciclin-containing family; it functions as part of matricellular proteins, and its production by airway epithelial cells is induced by IL-4 and IL-13. Periostin is secreted by fibroblasts and upregulated in the airway epithelia of patients with bronchial asthma; it is considered to contribute to remodeling under this pathological condition. However, despite many studies in diverse research areas, our overall understanding of this intriguing molecule is still inadequate. Here, we integrate the available evidence on periostin expression and its roles in otolaryngological diseases, including allergic rhinitis, chronic rhinosinusitis with nasal polyps, aspirin-induced asthma, organized hematoma, eosinophilic otitis media, and IgG4-related disease. Periostin might be involved as an important structural mediator in pathological processes such as insult and injury, Th2-driven inflammation, extracellular matrix restructuring, fibrosclerosis, tumor angiogenesis, and tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759558     DOI: 10.2332/allergolint.13-RAI-0673

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  9 in total

1.  Influence of Periostin on Synoviocytes in Knee Osteoarthritis.

Authors:  Yutaro Tajika; Tatsuya Moue; Shintaro Ishikawa; Kazuhito Asano; Takayuki Okumo; Hiroshi Takagi; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

Review 2.  Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis.

Authors:  Yao Yao; Shumin Xie; Chunguang Yang; Jianhui Zhang; Xuewen Wu; Hong Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-01       Impact factor: 2.503

3.  Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11).

Authors:  X Wen; Y-P Lei; Y L Zhou; C T Okamoto; M L Snead; M L Paine
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 4.  Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.

Authors:  Shigeharu Ueki; Nobuo Ohta; Masahide Takeda; Yasunori Konno; Makoto Hirokawa
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

Review 5.  Periostin: its role in asthma and its potential as a diagnostic or therapeutic target.

Authors:  Wei Li; Peng Gao; Yue Zhi; Wei Xu; Yanfeng Wu; Jinzhi Yin; Jie Zhang
Journal:  Respir Res       Date:  2015-05-17

6.  Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps.

Authors:  Takahiro Ninomiya; Emiko Noguchi; Takenori Haruna; Masayo Hasegawa; Takuto Yoshida; Yukiko Yamashita; Mitsuhiro Okano; Naohiro Yoshida; Shinichi Haruna; Yasunori Sakuma; Shoichiro Ohta; Junya Ono; Kenji Izuhara; Masafumi Okada; Masanori Kidoguchi; Takahiro Tokunaga; Masayuki Okamoto; Masafumi Kanno; Masafumi Sakashita; Tetsuji Takabayashi; Norihiko Narita; Shigeharu Fujieda
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

Review 7.  Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases.

Authors:  Anu Laulajainen-Hongisto; Sanna Katriina Toppila-Salmi; Annika Luukkainen; Robert Kern
Journal:  Front Cell Dev Biol       Date:  2020-03-27

8.  CD11c(+) dendritic cells coexpressing thymic stromal lymphopoietin receptor in animal model of eosinophilic otitis media.

Authors:  Ryutaro Hara; Naomi Kudo; Satoshi Suzuki; Tomoya Miura; Atsushi Matsubara
Journal:  Asia Pac Allergy       Date:  2020-10-26

9.  TLR2 deficiency promotes IgE and inhibits IgG1 class-switching following ovalbumin sensitization.

Authors:  Yuqin Li; Qiu Chen; Wei Ji; Yujie Fan; Li Huang; Chu Chu; Weifang Zhou
Journal:  Ital J Pediatr       Date:  2021-07-27       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.